Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Charles River Laboratories International Inc

+ Add to Watchlist


77.4000 USD 0.4900 0.63%

As of 20:04:04 ET on 04/24/2015.

Snapshot for Charles River Laboratories International Inc (CRL)

Open: 78.2100 Day's Range: 77.1600 - 78.2100 Volume: 494,431
Previous Close: 77.8900 52wk Range: 49.6000 - 84.6900 1-Yr Rtn: +36.63%

Stock Chart for CRL

No chart data available.
  • CRL:US 77.4000
  • 1D
  • 1M
  • 1Y
Interactive CRL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CRL

Current P/E Ratio (ttm) 25.8968
Estimated P/E(12/2015) 21.4523
Relative P/E vs. SPX 1.3856
Earnings Per Share (USD) (ttm) 2.9888
Est. EPS (USD) (12/2015) 3.6080
Est. PEG Ratio 2.1229
Market Cap (M USD) 3,671.85
Shares Outstanding (M) 47.44
30 Day Average Volume 492,027
Price/Book (mrq) 5.4494
Price/Sale (ttm) 2.7805
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CRL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CRL

Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company pro- vides the animal research models required in research and development for new drugs, devices, and therapies. Charles River's customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.

James C FosterChairman/President/CEODavid P JohstExec VP:HR/CAO/General Counsel
David SmithSenior VP:Global Discovery SvcsThomas F AckermanExec VP/CFO
More Company Profile & Key Executives for CRL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil